_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________Show more

OPT20-E023d September 2020.

_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________Show more

OPT20-E023c September 2020

_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________Show more

OPT20-E023a September 2020.

_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________Show more

OPT20-E023e September 2020.

_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________Show more

OPT20-E023b September 2020.

_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________Show more

BEO20-C039 June 2020.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at http://www.report.novartis.com/
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]